Market Size (2018)
2018
$3.91B
Vertical: HealthcareBase Year: 202112 Sections
Market Size (2018)
2018
$3.91B
Projected (2030)
2030
$16.96B
CAGR (2018–2030)
13.0%
13.0%Key Players
110+
This report covers Dermal Fillers Market with forecasts from 2018 to 2030. 110 key companies are profiled.
The Dermal Fillers Market market is projected to grow at a CAGR of 13.0% from 2018 to 2030.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Dermal Fillers Market from 2018 to 2030. Covers Asia Pacific, Rest of the World, Europe, North America.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2021
Historical Period
2018 – 2021
Forecast Period
2021 – 2030
Primary Interviews
150+
Historical data (2018–2021) and forecast period (2021–2030)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2030)
InsightNorth America leads with $7.14B by 2030, while Asia Pacific is projected to grow fastest at a 14.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2018 | 2021 | 2030 | CAGR | SHARE |
|---|---|---|---|---|---|
| Asia Pacific | $717.02M | $1.48B | $3.64B | 14.5% | 21% |
| Rest of the World | $494.17M | $793.68M | $1.49B | 9.7% | 9% |
| Europe | $1.11B | $2.09B | $4.69B | 12.7% | 28% |
| North America | $1.58B | $3.10B | $7.14B | 13.4% | 42% |
| Total | $3.91B | $7.47B | $16.96B | 13.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$16.96B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Hyaluronic Acid | $14.36B | 13.0% | 72% |
| Calcium Hydroxylapatite | $1.40B | 13.0% | 82% |
| Poly-L-Lactic Acid | $780.63M | 13.0% | 77% |
| Others | $421.79M | 13.0% | 53% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Dermal Fillers Market covering market dynamics, competitive landscape, and strategic outlook.
The Dermal Fillers Market market is projected to reach $16.96B by 2030, growing at 13.0% CAGR. The Hyaluronic Acid segment holds the largest share.
The Dermal Fillers Market market encompasses 4 key regions and 4 market segments, with the study period spanning 2018 to 2030. The market demonstrates a 13.0% compound annual growth rate, reflecting strong underlying demand fundamentals.
Among the identified segments, Hyaluronic Acid leads with $14.36B by 2030, followed by Calcium Hydroxylapatite at $1.40B. These segments collectively account for the largest share of total market revenue.
This report profiles 110 key companies operating in the Dermal Fillers Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Abbvie Inc. , Dr. Korman Laboratories, Teoxane Laboratories , SciVision Biotech Inc. , Bridgepoint Group Plc., and 105 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 110 companies operating in the Dermal Fillers Market market, including revenue, employee count, and market positioning where available.
Showing 110 of 110 companies
Bridgepoint Group Plc.
Company Headquarters: London, England Founded: 1984 Workforce: ~250 Company Working: Bridgepoint is an international alternative asset fund management firm providing private equity and private debt lending solution. The company offers its dermal fillers products through the subsidiary Vivacy (France) offers the manufacturing and distribution of injectable medical devices which is used in aesthetic treatments. The company has a strong medical aesthetic distribution network in more than 80 countries.
Abbvie Inc.
Company Overview Company Headquarters: Illinois, US Founded: 2013 Workforce: 30,000+ Company Working: Abbvie Inc. (Abbvie) is a pharmaceutical company that deals in various products addressing a variety of therapeutic areas such as oncology, immunology, neuroscience, virology, and general medicine. The company’s team consists of scientists, researchers, communicators, manufacturing specialists, and regulatory experts all across the globe. Abbvie targets specific difficult-to-cure diseases where it can leverage its core R&D expertise to advance science. It constantly works towards creating solutions that go beyond treating the illness to have a positive impact on patients’ lives and societies. The company comes up with new approaches towards addressing current health issues from life-threatening illness to chronic conditions.
Medytox
Company Headquarters: Seoul, South Korea Founded: 2000 Workforce: ~280 Company Working: Medytox is a pharmaceutical company that manufactures, markets, and distributes medical aesthetics products across the globe. The company operates through business segments including, botulinum toxin products hyaluronic acid filler medical devices, and prescription drugs. Additionally, the company provides comfort dual, a medical device for tissue coagulation by using a high-frequency, and presently, Medytox exports its products to about 60 countries, including Brazil and Japan. company is planning to expand its business in the Americas and European countries through its subsidiaries Medytox US, Medybloom China, Medytox Taiwan, Medytox Hong Kong, MedyCeles, and MDT International (Japan). It has three manufacturing plants and one R&D center based in South Korea.
SciVision Biotech Inc.
Company Headquarters: Taiwan Founded: 2001 Workforce: ~15 Company Working: SciVision Biotech Inc. is involved in the manufacturing and marketing of hyaluronic acid products in Taiwan. The company operates through the following segments, namely, absorbable adhesion barriers, dermal implants, synovial fluid supplements, intravesical instillations, and skincare products. The company operates through several business areas, such as aesthetics and skincare.
Suneva Medical
Company Headquarters: California, US Founded: 2009 Workforce: ~104 Company Working: Suneva Medical Inc., is a medical technology company. It is engaged in the manufacturing and distribution of aesthetics and skincare products. The company offers products to treat acne, wrinkles, and skin regeneration. The US, Canada, South Korea, Hong Kong, and Singapore are the major markets covered by Suneva Medical, Inc. In 2017, the company celebrated ten years of its flagship brand, Bellafill. Moreover. The firm's recently enlarged portfolio offers suppliers cutting-edge, scientifically supported products that aim to solve important patient needs safely and effectively.
Teoxane Laboratories
Company Headquarters: Geneva, Switzerland Founded: 2003 Workforce: ~500 Company Working: Teoxane Laboratories (Teoxane) is specialized in the designing and manufacturing of hyaluronic acid (HA)-based dermal fillers and cosmeceuticals. The company offers skin treatment products that are used for reducing wrinkles, restoring youthful volume to the face, and treating the neck and décolleté with-looking natural results. It focuses on medical devices, aesthetic products, skin care, beauty, anti-aging solutions, dermal fillers, and dermis redensification. The company has a strong distribution network in more than 95 countries as well as more than 10 subsidiaries in France, UK, Italy, Spain, Germany, Switzerland, Poland, Australia, Russia, Dubai, and Singapore.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Dermal Fillers Market